Laboratory monitoring of rivaroxaban in Chinese patients with deep venous thrombosis: a preliminary study

BACKGROUND: Rivaroxaban, a novel oral anticoagulant drug, is widely used in clinical practice. There is no standardized laboratory monitoring for rivaroxaban, and its plasma concentration in Chinese patients with deep vein thrombosis is unclear. The rivaroxaban concentrations in human plasma and det...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ying, Du, Liping, Tang, Xiaowan, Chen, Yuexin, Mei, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257180/
https://www.ncbi.nlm.nih.gov/pubmed/32466800
http://dx.doi.org/10.1186/s40360-020-00414-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257180/
https://www.ncbi.nlm.nih.gov/pubmed/32466800
http://dx.doi.org/10.1186/s40360-020-00414-5

Ejemplares similares